Multidisciplinary approach to reducing pharmaceutical misuse
Hospitalisations for pharmaceutical opioid poisoning now exceed those for heroin use. In fact, most people who enter Australian drug and alcohol treatment programs are doing so because of prescription opioid and/or benzodiazepine use (Aust Prescr 2014; 37: 79-81). Mortality associated with prescription opioid use is on the rise, and around 40% of deaths involve a legitimate prescription for oxycodone for non-cancer pain (Forensic Sci Med Pathol 2015; 11: 3-12).
The National Pharmaceutical Drug Misuse Framework for Action identifies national priorities to minimise harm from pharmaceutical drug misuse. Under the nine priority areas, there are a number of actions designed to support the entire health care team involved in medicine management, including prescribers and pharmacists.
NPS MedicineWise recently launched an online module to help pharmacists identify and manage prescription drug misuse as part of the broader care team. Often pharmacists are well placed to identify issues and improve quality use of medicines in patients they see in their pharmacies. This can be done by influencing the way an individual uses medicines, but also by identifying and relaying concerns back to the prescriber about potential misuse.
The module aims to help pharmacists improve their integration into a multidisciplinary care team, and offers suggestions and ideas to help pharmacy cultivate closer ties with general…